Contact ATCC Federal Solutions
ATCC, a non-profit organization founded in 1925, is the world’s most diverse biological resource center, supporting public health initiatives for the US government, academia, the pharmaceutical industry, and research foundations.
For more than 50 years, we have supported federal agencies through contracts focused on global health and infectious diseases, biodefense, chronic diseases, clinical study support, global logistics, and biorepository establishment/maintenance - all combined with our commitment to quality and responsive management. ATCC provides federal agencies with curated, high quality biomaterials and resources, laboratory services, and repository operations.
Biological and Emerging Infections Research Resources Program (BEI Resources) was established by the National Institute of Allergy and Infectious Diseases (NIAID) to provide reagents, tools and information for studying Category A, B, and C priority pathogens, emerging infectious disease agents, non-pathogenic microbes and other microbiological materials of relevance to the research community.
Get detailsThe International Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC) to provide registered users with reagents, test kits, and information for the study and detection of emerging bacterial and viral pathogens, as well as outbreak response.
Get detailsFocus areas
Biological Resource Support
ATCC operates and manages biological resource programs, including new product development, accessions, production, authentication, storage, and distribution.
Learn about our expertiseClinical Study Support
ATCC provides clinical and epidemiological study support to include provision of collection supplies, sample receipt and storage, biospecimen processing, and distribution.
Explore nowGlobal Health and Biodefense
ATCC supports government agencies with R&D services, subject matter expertise, diagnostic tools, and surveillance kits for infectious and chronic diseases.
Learn moreFeatured blog posts
Featured presentations and publications
Scientific posters
Palm Springs Symposium on HIV/AIDS 2024
ISBER 2024
CIVICs Annual Meeting 2024
- hCK-MDCK Cell Bank Availability through BEI Resources
- sMDCK Cell Bank Availability through BEI Resources
MHSRS 2024
- Large Scale Manufacturing and Evaluation of hTERT-Immortalized MSC-Derived Extracellular Vesicles for Reversal of Irradiation-Induced Cellular Damage
- Evaluation of a New Multiplex Lateral Flow Immuno-Assay (LFIA)-Based Point-of-Care Test (POCT) for Rapid Diagnosis of Invasive Fungal Infections (IFIS) in Field-Level
CIDR 2024
- Malaria gametocytes production in the Wave Bioreactor: optimizing yields and quantification protocols
- Composition of hypoxic gas mixture affects readouts of the Malaria Ring-Stage Survival Assay
- Detection of Adventitious Agents Using Next Generation Sequencing Technology
- Yellow Fever Surveillance with MAC-HD ELISA Assays
- Benchmarking the Scale-X Bioreactor System for Production of Influenza Virus
- Large-scale Production of Stem Cell Extracellular Vesicles for Cellular Repair
- Generation of a Full Thickness Human Skin Equivalent for In Vitro Functional Studies
- DNA nanoswitch strategy, a device-free platform for viral RNA detection
- Test for Infectivity of Inactivation Procedures for Positive-Strand RNA Viral Genomes
- Determined Requirements to Ensure the Effectivity of Inactivated SARS Coronavirus
ASTMH 2024
- In vitro screening of potential inhibitors targeting a putative Cryptosporidium transportin
- Optimizing protocols and strategies for the measurement of antimalarial drug levels using ELISA-based methods
IABS 2024
Peer-reviewed publications
hTERT-Immortalized Mesenchymal Stem Cell-Derived Extracellular Vesicles: Large-Scale Manufacturing, Cargo Profiling, and Functional Effects in Retinal Epithelial Cells
Hindle J, et al. Cells 13(10): 861, 2024. PubMed: 38786083
In vitro antimalarial susceptibility profile of Plasmodium falciparum isolates in the BEI Resources repository
Ahmed AO, et al. Antimicrob Agents Chemother 68(10): e0118923, 2024. PubMed: 9269188
Analysis of the Unique Historical Isolate of African Swine Fever Virus Isolate Spencer from Outbreaks in 1951
Spinard E, at al. Viruses 16(8): 1175, 2024. PubMed: 39205149
Establishment of human post-vaccination SARS-CoV-2 standard reference sera
Xiang J, et al. J Immunol Methods 530: 113698, 2024. PubMed: 38823574
White papers
Genomic DNA Extracted from Heparinized Whole Blood Using AutoGen FlexSTAR
Sadural H, Ghosh S. Autogen.
Featured news releases
ATCC Secures OASIS+ Multi-Agency Contract Vehicle from GSA
ATCC secures five-year, unrestricted OASIS+ multi-agency contract from GSA, expanding federal access to public health solutions.
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
NCI awarded ATCC a 5-year contract with a ceiling value of $4.06 million to provide lab services that support HIV and HTLV-1 research and vaccine development.
ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development
ATCC awarded a one-year, subaward in the amount of $165,962 from NIAID to collaborate on babesiosis and tickborne disease research.
ATCC Receives Grant from NIH to Build New Biomanufacturing Suite at its Manassas Headquarters
ATCC received a C06 Research Facilities Construction Grant from ORIP, part of the NIH, to support the building of ATCC’s new biomanufacturing suite at its headquarters in Manassas, VA.
ATCC Federal Solutions Leadership
Rebecca Bradford, MBA, MS, PMP
Senior Vice President, ATCC Federal Solutions
Rebecca is responsible for the overall strategy, management, and growth of AFS programs, including products and services for chronic and emerging infectious diseases, medical countermeasures, and global health security.
Eldar Imanverdi
Senior Director, Business Development, ATCC Federal Solutions (AFS)
Eldar is Senior Director of Business Development at AFS, driving new market entry aligned with AFS’s growth strategy. With over 25 years’ experience across private and nonprofit sectors, international operations, and strategic business development, his expertise spans global health, biosecurity programs, marketing, and customer relations. Drawing on his extensive background, Eldar has secured significant opportunities with the U.S. Department of State, CDC, NIH, USDA, and DTRA.
Sujatha Rashid, PhD, PMP
Director, Government Programs, ATCC Federal Solutions (AFS)
Sujatha is a Director of Government Programs at ATCC and is responsible for managing a portfolio of NIAID programs including BEI Resources and the HIV Reagent Program. She is a subject matter expert in medical and clinical virology. Sujatha has been with AFS since 2008 and is responsible for providing scientific leadership for emerging infectious diseases and pandemic response and preparedness.
Carla Williams Smith
Director, Contracts, ATCC Federal Solutions (AFS)
Carla is a Director of Contracts for ATCC Federal Solutions and is responsible for managing all contractual, financial and administrative aspects of ATCC’s federal programs. Carla is an expert in the contract and proposal process and ensures ATCC adheres to all laws, regulations, and policies.
Heather Couch, PhD, PMP
Director, Government Programs, ATCC Federal Solutions (AFS)
Heather serves as the Director of Government Programs at ATCC, where she leads a multifaceted portfolio of contracts in support of federal partners including the CDC and FDA. Her work centers on ensuring access to essential reagents and diagnostics critical to disease surveillance and pandemic preparedness. Leveraging her deep expertise in science, technology, and program management, Heather fosters innovation and strategic collaboration to advance public health outcomes.
ATCC Greenhouse Gas Emissions Report
Read our reportATCC Corporate Policy – Federal Awards Conflict Of Interest
Read our policyContact ATCC Federal Solutions
Thank you for your interest in ATCC Federal Solutions. Please fill out the form and let us help you meet your goals.
Thank you!
